ReviewMicrobial cell factories2015
A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe.
Review in Microbial cell factories, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Choosing an appropriate probiotic product for your patient: An evidence-based practical guide.PloS one · 2018Pooled it
- Key Safety Criteria for Novel Microbial Food Ingredients: A Comparative Analysis of International Regulatory Frameworks.Journal of microbiology and biotechnology · 2026Review
- Faecalibacterium: a bacterial genus with promising human health applications.FEMS microbiology reviews · 2023Review
- An Isolate ofNutrients · 2023Article
- Quantitative and qualitative characterization of commercially available oral suspension of probiotic products containing Bacillus Clausii spores.BMC microbiology · 2022Article
- Description of a Newly IsolatedNutrients · 2022Article
- Evaluation of Potential Probiotic Properties of a Strain ofFrontiers in microbiology · 2022Article
- Identification ofMicroorganisms · 2021Article
- Review
- Safety Assessment and Preliminary In Vitro Evaluation of Probiotic Potential of Lactococcus lactis Strains Naturally Present in Raw and Fermented Milk.Current microbiology · 2020Article
- The Development of High-Quality Multispecies Probiotic Formulations: From Bench to Market.Nutrients · 2020Review
- In Silico Comparison Shows that the Pan-Genome of a Dairy-Related Bacterial Culture Collection Covers Most Reactions Annotated to Human Microbiomes.Microorganisms · 2020Article
- Evaluation of Fresh Cheese Quality Prepared with Newly Isolated Nisin Z-Producing Lactococcus lactis Bacteria.Probiotics and antimicrobial proteins · 2019Article
- Binding activity to intestinal cells and transient colonization in mice of two Lactobacillus paracasei subsp. paracasei strains with high aggregation potential.World journal of microbiology & biotechnology · 2019Article
- Emerging Health Concepts in the Probiotics Field: Streamlining the Definitions.Frontiers in microbiology · 2019Article
- Probiotic Features of Lactic Acid Bacteria Isolated from a Diverse Pool of Traditional Greek Dairy Products Regarding Specific Strain-Host Interactions.Probiotics and antimicrobial proteins · 2018Article
- Probiotic Incorporation in Edible Films and Coatings: Bioactive Solution for Functional Foods.International journal of molecular sciences · 2018Review
- A Versatile New Model of Chemically Induced Chronic Colitis Using an Outbred Murine Strain.Frontiers in microbiology · 2018Article
- Searching for the Bacterial Effector: The Example of the Multi-Skilled Commensal BacteriumFrontiers in microbiology · 2018Article
- Bacteria isolated from lung modulate asthma susceptibility in mice.The ISME journal · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper concerns the procedure and the scientific approach to obtain market authorization for a microorganism to be recognized as a novel food with a health claim. Microorganisms that have not been traditionally used during food production in Europe prior to 1997 are considered as novel foods, which should undergo an in-depth characterization and safety assessment before being authorized on the European market. If a novel food bacterium is claimed to provide a beneficial effect on health, these claims must also be investigated before they can be authorized. Some requirements to obtain novel food certification are shared with those required to obtain a health claim. Although regulation exists that deals with these issues for foods in general, bacteria in food raise a specific set of questions that are only minimally addressed in official documentation. We propose a framework and suggest a list of criteria that should be assessed to obtain marketing authorization and health claim for a bacterium in accordance with European health policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.